Rhenman & Partners Asset Management’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Other funds holding SNY
Rhenman & Partners Asset Management's SNY Position: Q4 2017 in Review
Rhenman & Partners Asset Management sold out of Sanofi (SNY) in Q4 2017, closing a stake of 130,000 shares — an estimated $6.47M sold.
Rhenman & Partners Asset Management first reported a position in SNY in Q2 2017 and held it in 2 quarters. The position peaked at $7.67M in Q2 2017. 504 funds tracked by Wall St. Rank hold SNY as of Q4 2017.
- Rhenman & Partners Asset Management reported no remaining Sanofi position as of Q4 2017 after selling out during the quarter.
- Rhenman & Partners Asset Management sold 130,000 Sanofi shares in Q4 2017, an estimated $6.47M.
- Rhenman & Partners Asset Management first reported a position in Sanofi in Q2 2017 and held it in 2 quarters.
- Rhenman & Partners Asset Management's Sanofi position peaked at $7.67M in Q2 2017.
- 504 funds tracked by Wall St. Rank held Sanofi as of Q4 2017.
Based on Rhenman & Partners Asset Management's 13F filing for Q4 2017, filed 19 Jan 2018.